Whole Genetic Approach in Early Genetic Identification of Obesity (WEGIO)

Status: Active_not_recruiting
Location: See all (37) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

TITLE: Whole genetic approach in Early Genetic Identification of Obesity (WEGIO) DESIGN: Multicenter epidemiological study STUDY POPULATION: Participants at risk for a syndromic or a monogenic genetic obesity, incl. participants clinically diagnosed with Bardet-Biedl-Syndrome (BBS) NUMBER OF PARTICIPANTS: 1000 for initial genetic sequencing and app. 40 for the follow-up documentation COORDINATING INVESTIGATOR: Prof. Dr. Arndt Rolfs

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
View:

• Informed consent is obtained from the participant/parent/legal guardian

• The participant is 2 years of age or older

⁃ For a participant between 2 and 18 years of age:

• The participant has and had a body weight more than 97th percentile before the age of 6

• The participant has one or more of the following symptoms:

⁃ rod/cone dystrophy, renal abnormalities, ataxia, syndactyly, polydactyly, brachydactyly, hyperphagia, cognitive impairment, speech delay, hypogonadism

⁃ For a participant who is 18 years of age or older:

• The participant has BMI ≥ 30 kg/m2

• The participant had a body weight more than 97th percentile before the age of 6 years

• The participant has rod/cone dystrophy

• The participant is 2 or more years of age, is clinically diagnosed with Bardet-Biedl-Syndrome (BBS) or is a sibling of an individual diagnosed with BBS via the WEGIO study

Locations
Other Locations
Germany
Universitätsklinikum Aachen (RWTH)
Aachen
KJF Klinik Josefinum
Augsburg
Universitätsklinikum Augsburg - Klinik für Kinder- und Jugendmedizin
Augsburg
Universitätsklinikum Freiburg
Bad Krozingen
Klinikum Bielefeld Mitte
Bielefeld
Universitätsklinikum Bonn
Bonn
Praxis für Endokrinologie Dr. Daniel Pfaff
Bückeburg
Cellitinnen-Krankenkaus St. Franziskus
Cologne
Universitätsmedizin Essen
Essen
Klinikum Frankfurt (Oder)
Frankfurt (oder)
SRH Wald-Klinikum Gera
Gera
Universitätsmedizin Göttingen - Klinik für Kinder- und Jugendmedizin
Göttingen
WolfartKlinik
Gräfelfing
Universitätsmedizin Greifswald - Klinik und Poliklinik für Innere Medizin A
Greifswald
Katholisches Kinderkrankenhaus WILHELMSTIFT
Hamburg
Kinder- und Jugendkrankenhaus Auf der Bult
Hanover
Hormonzentrum Heidelberg
Heidelberg
Kinder- und Jugendarztpraxis Nebras Mohammad
Iserlohn
Universitätsklinikum Jena
Jena
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Kiel
Sozialpädiatrisches Zentrum Leipzig
Leipzig
Universitätsmedizin Mannheim - Augenklinik
Mannheim
Städtische Kliniken Mönchengladbach - Elisabeth-Krankenhaus Rheydt
Mönchengladbach
Kinder- und Jugendarztpraxis Sulaiman Al Sawaf
Nettetal
Dietrich-Bonhoeffer-Klinikum
Neubrandenburg
Hausarztpraxis Rahman & Detho
Obertshausen
Sana Klinikum Offenbach
Offenbach
Kinderärzte am Leo
Pforzheim
Klinikum Ernst von Bergmann
Potsdam
Elblandklinikum Riesa
Riesa
GPR Klinikum Rüsselsheim
Rüsselsheim Am Main
Kinder- und Jugendpraxis Dogan
Stuttgart
SRH Zentralklinikum Suhl GmbH
Suhl
Praxis für Kinder- und Jugendmedizin Dr. med. Tabea Tippelt
Velbert
Dreifaltigkeits-Krankenhaus Wesseling
Wesseling
Praxis für Kinder- und Jugendmedizin Seyfullah Gökce
Wiesbaden
Universitätsklinikum Würzburg - Medizinische Klinik und Poliklinik I
Würzburg
Time Frame
Start Date: 2024-01-24
Completion Date: 2027-03-01
Participants
Target number of participants: 1000
Treatments
Participants suspected to genetic obesity
Participants suspected to genetic obesity
Sponsors
Collaborators: Rhythm Pharmaceuticals, Inc.
Leads: Rolfs Consulting und Verwaltungs-GmbH (RCV)

This content was sourced from clinicaltrials.gov